Release Date: 02/08/10 14:27 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 11.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%